title: Methotrexate-induced lymphoproliferative disease: Epstein-Barr virus-associated lymphomatoid granulomatosis.
authors.affiliation: Department of General Internal Medicine 4, Kawasaki Hospital, Kawasaki Medical School, 2-1-80, Nakasange, Kita-ku, Okayama, 700-8505, Japan.
authors.forename: Nobuaki
authors.initials: N
authors.lastname: Ochi
authors.forename: Hiromichi
authors.initials: H
authors.lastname: Yamane
authors.forename: Tomoko
authors.initials: T
authors.lastname: Yamagishi
authors.forename: Yasumasa
authors.initials: Y
authors.lastname: Monobe
authors.forename: Nagio
authors.initials: N
authors.lastname: Takigawa
mesh_terms: D000368:Aged; D001172:Arthritis, Rheumatoid / Q000175:diagnosis / Q000188:drug therapy; D001707:Biopsy, Needle; D003287:Contrast Media; D004305:Dose-Response Relationship, Drug; D020031:Epstein-Barr Virus Infections / Q000139:chemically induced* / Q000175:diagnosis; D005260:Female; D005500:Follow-Up Studies; D004854:Herpesvirus 4, Human / Q000187:drug effects* / Q000302:isolation & purification; D006801:Humans; D007150:Immunohistochemistry; D008175:Lung Neoplasms / Q000139:chemically induced* / Q000175:diagnosis / Q000821:virology; D008230:Lymphomatoid Granulomatosis / Q000139:chemically induced* / Q000175:diagnosis / Q000821:virology; D008727:Methotrexate / Q000009:adverse effects* / Q000627:therapeutic use; D016133:Polymerase Chain Reaction; D018570:Risk Assessment; D014057:Tomography, X-Ray Computed / Q000379:methods
chemical_list: D003287:Contrast Media; D008727:Methotrexate